Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

ANGLE plc: Prostate Cancer ARV7 Treatment Biomarker

ANGLE plc, a world-leading liquid biopsy company, announced that the University Medical Centre Hamburg-Eppendorf (UKE) together with the Medical University of Graz (Graz) and the Science for Life Laboratory, Stockholm University (SciLifeLab) have published results of work demonstrating that ANGLE’s Parsortix™ system can be used to measure the expression of ARV7(androgen receptor splice variant 7) transcripts in later stage prostate cancer patients.

Read more.

source: ANGLE plc